RecruitingNot applicableNCT06497829
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
Studying Mevalonate kinase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Motol
- Principal Investigator
- Anna Šedivá, MgrUniversity Hospital, Motol
- Intervention
- geranylgeraniol(dietary_supplement)
- Enrollment
- 6 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- University Hospital, Motol, Prague, Czechia
Collaborators
Washington University School of Medicine
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06497829 on ClinicalTrials.gov